NCT01819740
Unknown
N/A
Analysis of a New Biomarker for Prostate Cancer Diagnosis
Corporacion Parc Tauli1 site in 1 country28 target enrollmentApril 2013
ConditionsPatients With Suspected Prostate Cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Patients With Suspected Prostate Cancer
- Sponsor
- Corporacion Parc Tauli
- Enrollment
- 28
- Locations
- 1
- Primary Endpoint
- substance "HEM" concentration in seminal plasma (mEq/L measured by spectro-photometry
- Last Updated
- 13 years ago
Overview
Brief Summary
The aim of our study is to determine if the levels of the "HEM" substance in seminal plasma are associated with the presence of prostate cancer in transrectal prostate biopsy.
Investigators
MIRIAM BARRIO MUÑOZ
UROLOGY RESIDENT
Hospital de Sabadell
Eligibility Criteria
Inclusion Criteria
- •Clinical or laboratory suspected of prostate cancer
Exclusion Criteria
- •Inability to ejaculate
Outcomes
Primary Outcomes
substance "HEM" concentration in seminal plasma (mEq/L measured by spectro-photometry
Time Frame: 1 hour
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
N/A
To Identify Potential New Urine Markers for the Screening of Prostate CancerProstate CancerNCT03914391Chinese University of Hong Kong10,000
Recruiting
N/A
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer PatientsProstate CancerNCT03237026National Taiwan University Hospital360
Withdrawn
N/A
Investigation of Protein Biomarkers of Prostate CancerProstate CancerNCT00323180University of New Mexico
Terminated
N/A
Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic SecretionsProstate CancerNCT00250757New Mexico Cancer Care Alliance101
Withdrawn
N/A
Investigation of Urinary Biomarkers for the Detection of Prostate CancerProstate CancerUrineLiquid BiopsyNCT05454371Novosanis NV